Stacey Dillon

Stacey Dillon has extensive work experience in the field of immunology and translational medicine. Stacey is currently the Vice President of Translational Medicine at Alpine Immune Sciences, Inc., a position they have held since November 2021. Prior to this, they served as the Senior Director of Translational Sciences at the same company from October 2016 to November 2021.

Before joining Alpine Immune Sciences, Inc., Stacey worked at ZymoGenetics, Inc., a subsidiary of Bristol-Myers Squibb Company. Stacey held the role of Director of Immuno-Oncology Discovery from March 2011 to September 2016. Stacey also worked as an Associate Director at ZymoGenetics, Inc. from March 2010 to March 2011 and as a Principal Scientist from March 1999 to June 2010.

Earlier in their career, Stacey was a Postdoctoral Fellow at Johns Hopkins University from 1996 to 1999. Stacey pursued their undergraduate studies at the University of California, San Diego from 1985 to 1989.

Overall, Stacey Dillon has held various positions of increasing responsibility and expertise in the fields of immunology, translational medicine, and immuno-oncology.

Stacey Dillon completed their Ph.D. in Immunology at the University of Washington from 1990 to 1995. Following this, they pursued a Post-Doctoral Fellowship at The Johns Hopkins University from 1996 to 1999, specializing in Immunology with a focus on B cell development and tolerance.